Blue Owl Capital Holdings LP Larimar Therapeutics, Inc. Put Options Transaction History
Blue Owl Capital Holdings LP
- $185 Million
- Q2 2025
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding LRMR
# of Institutions
128Shares Held
66.1MCall Options Held
4.83MPut Options Held
83.7K-
Deerfield Management Company, L.P. (Series C) New York, NY21.2MShares$78.6 Million1.41% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$22.4 Million0.38% of portfolio
-
Opaleye Management Inc. Boston, MA4.11MShares$15.2 Million2.84% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.66MShares$13.5 Million0.01% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$12.6 Million6.65% of portfolio
About Larimar Therapeutics, Inc.
- Ticker LRMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,269,200
- Market Cap $160M
- Description
- Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...